ONE-MONTH HOSPITALIZATION WITH HIGH-DOSE GLUCOCORTICOID THERAPY IS ASSOCIATED WITH SARCOPENIA PROGRESSION IN PATIENTS WITH RHEUMATIC MUSCULOSKELETAL DISEASES

被引：0
|
作者：
Hanaoka, H. [1 ]
Kikuchi, J. [1 ]
Akiyama, M. [1 ]
Hiramoto, K. [1 ]
Saito, S. [1 ]
Kondo, Y. [1 ]
Kaneko, Y. [1 ]
机构：
[1] Keio Univ, Div Rheumatol, Dept Internal Med, Sch Med, Tokyo, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Diet and nutrition; Comorbidities; Best practices;
D O I：
10.1136/annrheumdis-2023-eular.1734
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1643
引用
收藏
页码：2056 / 2056
页数：1
相关论文
共 50 条
  • [31] Bisphosphonate is effective for primary prevention of high-dose glucocorticoid-induced osteoporosis in patients with systemic autoimmune diseases.
    Nakayamada, S
    Saito, K
    Okada, Y
    Tanaka, Y
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S500 - S500
  • [32] Is high-dose β-lactam therapy associated with excessive drug toxicity in critically ill patients?
    Mcdonald, Craig
    Cotta, Menino O.
    Little, Peter J.
    Mcwhinney, Brett
    Ungerer, Jacobus P. J.
    Lipman, Jeffrey
    Roberts, Jason A.
    MINERVA ANESTESIOLOGICA, 2016, 82 (09) : 957 - 965
  • [33] Factors associated with poor antibody response to third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases
    Connolly, Caoitfhionn M.
    Chiang, Teresa Po-Yu
    Teles, Mayan
    Frey, Sarah
    Alejo, Jennifer L.
    Massie, Allan
    Shah, Ami A.
    Albayda, Jemima
    Christopher-Stine, Lisa
    Werbel, William A.
    Segev, Dorry L.
    Paik, Julie J.
    LANCET RHEUMATOLOGY, 2022, 4 (06): : E382 - E384
  • [34] RECHALLENGE WITH HIGH-DOSE VERAPAMIL IN PATIENTS WITH STABLE ANGINA AFTER ONE YEAR OF CONTINUOUS THERAPY
    WEINER, DA
    CUTLER, SS
    MCCABE, CH
    KLEIN, MD
    RYAN, TJ
    CIRCULATION, 1982, 66 (04) : 82 - 82
  • [35] Disease-related risk for symptomatic vertebral fracture during high-dose glucocorticoid treatment in female patients with collage vascular diseases: Subanalysis of Chiba-Shimoshizu rheumatic cohort
    Tatsuno, Ichiro
    Yoshida, Tomohiko
    Suzuki, Sawako
    Nagano, Hidekazu
    Hashimoto, Naoko
    Mayama, Takafumi
    Suyama, Keiko
    Tanaka, Tomoaki
    Sueishi, Makoto
    Yokote, Kotaro
    Sugiyama, Takao
    ENDOCRINE JOURNAL, 2010, 57 : S495 - S495
  • [36] High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases
    Ruddy, Jake A.
    Connolly, Caoilfhionn Marie
    Boyarsky, Brian J.
    Werbel, William A.
    Christopher-Stine, Lisa
    Garonzik-Wang, Jacqueline
    Segev, Dorry L.
    Paik, Julie J.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (10) : 1351 - +
  • [37] Risk-benefit analysis of isoniazid monotherapy to prevent tuberculosis in patients with rheumatic diseases exposed to prolonged, high-dose glucocorticoids
    Park, Jun Won
    Curtis, Jeffrey R.
    Lee, Hajeong
    Lee, Jung-Kyu
    Song, Yeong Wook
    Lee, Eun Bong
    PLOS ONE, 2020, 15 (12):
  • [38] Acute Alteration in Bone Mineral Density and Biochemical Markers for Bone Metabolism in Nephrotic Patients Receiving High-Dose Glucocorticoid and One-Cycle Etidronate Therapy
    T. Fujita
    A. Satomura
    M. Hidaka
    I. Ohsawa
    M. Endo
    H. Ohi
    Calcified Tissue International, 2000, 66 : 195 - 199
  • [39] Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy
    Fujita, T
    Satomura, A
    Hidaka, M
    Ohsawa, I
    Endo, M
    Ohi, H
    CALCIFIED TISSUE INTERNATIONAL, 2000, 66 (03) : 195 - 199
  • [40] Adverse effects associated with high-dose olanzapine therapy in patients admitted to inpatient psychiatric care
    Petersen, A. B.
    Andersen, S. E.
    Christensen, M.
    Larsen, H. L.
    CLINICAL TOXICOLOGY, 2014, 52 (01) : 39 - 43
12345